Hi @Joseph , yes CaAKG is interesting, and I agree, given the price premium for the Rejuvant , I can see why people would be “making their own”.
I’ve seen conflicting research on CaAKG in terms of mTOR inhibition and activation (see two papers below) but I have not researched it in depth. Have you researched this issue - or anyone else here?
More details for those interested in CaAKG:
And a report by the Alzheimer’s Drug Discovery Foundation on CaAKG: